What Is The Lawsuit About? The lawsuit has been filed on behalf of investors who purchased securities during the period of December 15, 2021 through September 16, 2025, inclusive ("the Class Period†). The lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Defendants engaged in tax fraud; (2) Defendants committed bribery to cover up the fact that they committed tax fraud; and (3) as a result, defendants understated the leg ...

NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, inclusive. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Fly-E Group, Inc. (NASDAQ: FLYE)?Did you purchase your shares between July 15, 2025 and August 14, 2 ...

RADNOR, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Dow Inc. (“Dow”) (NYSE: DOW) on behalf of those who purchased or otherwise acquired Dow securities between January 30, 2025, and July 23, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is October 28, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Dow losses, you may CLICK HERE or ...

Core Viewpoint - A securities class action lawsuit has been filed against Fluor Corporation for alleged misleading statements and undisclosed costs related to specific projects, impacting the company's financial guidance and business outlook [1][2]. Group 1: Allegations Against Fluor Corporation - The lawsuit claims that Fluor's management made false or misleading statements regarding the costs associated with the Gordie Howe International Bridge and highway projects in Texas, which were increasing due to subcontractor design errors, price hikes, and scheduling delays [2]. - It is alleged that these issues, along with reduced capital spending from customers and economic uncertainty, were likely to have a significant negative impact on Fluor's business and financial results [2]. - The complaint asserts that Fluor's financial guidance for fiscal year 2025 was unreliable, overstating the effectiveness of its risk mitigation strategy and understating the impact of economic uncertainty on its operations [2]. Group 2: Lead Plaintiff Process - Investors in Fluor have until November 14, 2025, to seek appointment as a lead plaintiff representative in the class action, which involves directing the litigation on behalf of all class members [3]. - The lead plaintiff is typically the investor or group of investors with the largest financial interest in the case and must be adequate and typical of the proposed class [3]. - Participation as a lead plaintiff does not affect an investor's ability to share in any recovery from the lawsuit [3].

Core Viewpoint - V.F. Corporation is facing a securities fraud class action lawsuit alleging misrepresentations about its business plans, with a deadline for investors to act by November 12, 2025 [3][4]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the District of Colorado on behalf of investors who purchased VFC securities between October 30, 2023, and May 20, 2025 [3]. - The allegations include violations of the Securities Exchange Act of 1934 against VFC and certain senior officers [3]. Group 2: Investor Actions - Investors who wish to serve as lead plaintiff must file papers by November 12, 2025, but participation as a lead plaintiff is not required to share in any recovery [4]. - All representation in the lawsuit is on a contingency fee basis, meaning shareholders pay no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years [5].

Core Viewpoint - Nutex Health Inc. is facing a securities fraud class action lawsuit, with allegations of materially false and misleading statements regarding its business and operations [3]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Southern District of Texas on behalf of investors who purchased Nutex securities between August 8, 2024, and August 14, 2025 [3]. - The lawsuit alleges violations of the Securities Exchange Act of 1934 against Nutex and certain senior officers [3]. Group 2: Legal Actions and Deadlines - Investors wishing to serve as lead plaintiffs must file papers by October 21, 2025 [4]. - Serving as a lead plaintiff is not required to share in any recovery, and all representation is on a contingency fee basis, meaning shareholders pay no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for its clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years [5].

Group 1 - The article discusses a securities fraud class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934 [2][3] - The lawsuit claims that Dow misrepresented its ability to handle macroeconomic challenges and maintain financial flexibility for dividends [3] - Investors who purchased Dow securities between January 30, 2025, and July 23, 2025, are eligible to participate in the lawsuit [2] Group 2 - A deadline for filing as a lead plaintiff in the class action is set for October 28, 2025 [4] - The law firm Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized for its litigation success [5]

Core Viewpoint - A securities class action lawsuit has been filed against Dow Inc. for allegedly making false and misleading statements regarding its financial condition and ability to manage macroeconomic challenges during the Class Period from January 30, 2025, to July 23, 2025 [1][2]. Summary by Relevant Sections Allegations Against Dow Inc. - The lawsuit claims that Dow overstated its ability to handle macroeconomic and tariff-related challenges, as well as to maintain financial flexibility for its dividend [2]. - It is alleged that the true impact of competitive pressures, declining global sales, and product oversupply on Dow's business was significantly understated [2]. - The complaint asserts that Dow's public statements were materially false and misleading throughout the Class Period [2]. Lead Plaintiff Process - Investors in Dow can seek to be appointed as lead plaintiffs by October 28, 2025, through Kessler Topaz Meltzer & Check, LLP or other legal counsel [3]. - A lead plaintiff represents the interests of all class members and typically has the largest financial stake in the case [3]. - Participation as a lead plaintiff does not affect the ability to share in any recovery from the lawsuit [3]. Firm Background - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions and has a reputation for recovering billions for victims of corporate misconduct [4]. - The firm aims to protect investors and others from fraud and negligence by businesses [4].

Group 1 - The article discusses a securities fraud class action lawsuit against V.F. Corporation (VFC), reminding investors of an upcoming deadline to participate [1][4]. - The lawsuit was filed in the United States District Court for the District of Colorado, alleging that VFC and certain senior officers made misrepresentations regarding the company's business plans between October 30, 2023, and May 20, 2025 [4]. - Investors who wish to serve as lead plaintiffs must file papers by November 12, 2025, although participation as a lead plaintiff is not required to share in any potential recovery [5]. Group 2 - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has a strong track record in class action litigation [6].

Core Viewpoint - Savara Inc. is facing a securities fraud class action lawsuit following a significant decline in its stock price after the FDA issued a refusal to file letter for its MOLBREEVI BLA therapy [3][4]. Group 1: Company Overview - Savara Inc. (NASDAQ:SVRA) is involved in the development of therapies, specifically the MOLBREEVI BLA intended for treating patients with aPap [3]. - The company experienced a stock price drop of approximately 31.69%, from $2.84 on May 23, 2025, to $1.94 on May 27, 2025, after the FDA's announcement [3]. Group 2: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Savara securities between March 7, 2024, and May 23, 2025 [4]. - Allegations in the lawsuit include that Savara made false or misleading statements regarding the completeness of the MOLBREEVI BLA submission and the likelihood of FDA approval [4]. - The lawsuit claims that the company failed to disclose the need for additional data related to Chemistry, Manufacturing, and Controls (CMC), which impacted the approval timeline and raised concerns about the need for additional capital [4].